Skip to main content

Test

Secretome Therapeutics · Secretome Therapeutics is a clinical-stage cell therapy company that develops therapies for rare cardiac diseases.

Plano, TX400 Series - Mfg/CMC R&D11-50 employeesPosted 4 days ago
Series A · $30Mraised 4 months agoled by RA Capital Management, TEDCO, University System of Maryland Momentum Fund

This board only lists companies whose most recent round closed in the last 180 days.

Apply on Secretome Therapeutics’s site

Secretome Therapeutics is a clinical-stage biotechnology company based in Plano, Texas, developing novel therapies derived from neonatal cardiac progenitor cells (nCPC). The Company's lead product candidate, STM-01, is a cellular therapy designed to modulate inflammatory and fibrotic pathways and support myocardial function in Duchenne Muscular Dystrophy (DMD) and Heart Failure with Preserved Ejection Fraction (HFpEF). Secretome is also advancing STM-21, a secretome-based therapeutic currently in preclinical development, and other novel nCPC-based products.

About the role

  • Describe the role and team the candidate will be joining

What you'll do

  • Describe the specific responsibilities and job functions of the role

Qualifications

  • Describe the experience and attributes of the ideal candidate
Apply on Secretome Therapeutics’s site

Applications go straight to the employer. VCBacked does not sit between you and the company.

1,300 more roles posted in the last 48 hours

You are seeing the board after its 48-hour member window. Job Seeker opens that window and sends an alert the moment a role hits — applicants in the first 24 hours land 90 percent of interviews.

Back to all roles at freshly funded companies